Annual Total Debt
$7.88 M
+$1.26 M+19.00%
December 31, 2023
Summary
- As of February 26, 2025, EPRX annual total debt is $7.88 million, with the most recent change of +$1.26 million (+19.00%) on December 31, 2023.
- During the last 3 years, EPRX annual total debt has fallen by -$2.13 million (-21.32%).
- EPRX annual total debt is now -21.32% below its all-time high of $10.01 million, reached on December 1, 2020.
Performance
EPRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$93.10 K
-$4.57 M-98.00%
September 1, 2024
Summary
- As of February 26, 2025, EPRX quarterly total debt is $93.10 thousand, with the most recent change of -$4.57 million (-98.00%) on September 1, 2024.
- Over the past year, EPRX quarterly total debt has stayed the same.
- EPRX quarterly total debt is now -99.18% below its all-time high of $11.34 million, reached on September 30, 2023.
Performance
EPRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
EPRX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.0% | 0.0% |
| 3 y3 years | -21.3% | -98.8% |
| 5 y5 years | +182.9% | +100.0% |
EPRX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.0% | -99.2% | -100.0% |
| 5 y | 5-year | -21.3% | +19.0% | -99.2% | -100.0% |
| alltime | all time | -21.3% | >+9999.0% | -99.2% | -100.0% |
Eupraxia Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $93.10 K(-98.0%) |
| Jun 2024 | - | $4.66 M(-51.2%) |
| Mar 2024 | - | $9.56 M(-8.6%) |
| Dec 2023 | $7.88 M(+19.0%) | $10.45 M(-7.8%) |
| Sep 2023 | - | $11.34 M(+35.0%) |
| Jun 2023 | - | $8.40 M(>+9900.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $6.62 M(-11.7%) | - |
| Dec 2022 | - | $8.99 M(+19.4%) |
| Sep 2022 | - | $7.52 M(-3.3%) |
| Jun 2022 | - | $7.78 M(-0.7%) |
| Mar 2022 | - | $7.83 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $7.49 M(-25.2%) | $7.49 M(+1.9%) |
| Sep 2021 | - | $7.35 M(+3.1%) |
| Jun 2021 | - | $7.13 M(+41.6%) |
| Mar 2021 | - | $5.03 M(-49.7%) |
| Dec 2020 | $10.01 M(+9.6%) | $10.01 M(+6.1%) |
| Sep 2020 | - | $9.44 M(>+9900.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $9.14 M(+228.2%) | $9.14 M(>+9900.0%) |
| Sep 2019 | - | $0.00 |
| Dec 2018 | $2.78 M(>+9900.0%) | - |
| Dec 2017 | $9900.00 | - |
FAQ
- What is Eupraxia Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual total debt year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly total debt year-on-year change?
What is Eupraxia Pharmaceuticals annual total debt?
The current annual total debt of EPRX is $7.88 M
What is the all time high annual total debt for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual total debt is $10.01 M
What is Eupraxia Pharmaceuticals annual total debt year-on-year change?
Over the past year, EPRX annual total debt has changed by +$1.26 M (+19.00%)
What is Eupraxia Pharmaceuticals quarterly total debt?
The current quarterly total debt of EPRX is $93.10 K
What is the all time high quarterly total debt for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly total debt is $11.34 M
What is Eupraxia Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, EPRX quarterly total debt has changed by $0.00 (0.00%)